Clinical Application of Mass Spectrometry‐Based Proteomics in Lung Cancer Early Diagnosis. Issue 5 (22nd June 2020)

• Record Type: Journal Article
• Authors: Gasparri, Roberto; Sedda, Giulia; Noberini, Roberta; Bonaldi, Tiziana; Spaggiari, Lorenzo
• Is Part Of: Proteomics. Volume 14:Issue 5(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-06-22
• Subjects: lung cancer -- proteomics -- translational medicine; Proteomics -- Periodicals; 572.605
• DOI: 10.1002/prca.201900138
• Languages: English
• ISSNs: 1862-8346

Abstract

Abstract : The current knowledge on proteomic biomarker analysis for the early diagnosis of lung cancer is summarized, underlining the diversity among the results and the current interest in translating research results into clinical practice. A MEDLINE/PubMed literature search to retrieve all the papers published in the last 10 years is performed. Proteomics studies on lung cancer have gathered evidence on the potential role of biomarkers in early diagnosis. Although promising, none of them have proved to be sufficiently reliable to achieve validation. Future research should evolve toward a multipanel analysis of proteins, considering the possibility that individual biomarkers might not be specific enough to diagnose lung cancer, but could be related to oncological conditions.